Merrimack Pharmaceuticals, Inc. MACK
15.15 +15.15
Day range unavailable
52-week range unavailable
Revenue & Expenses
Latest period ending Dec 31, 2023 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| 2.04M | 1.73M | 2.47M | 2.87M | 22.36M | |
| 2.18M | 2.17M | 2.62M | 5.01M | 16.17M | |
| -2.04M | -1.73M | -2.47M | -2.87M | -22.36M | |
| 12.00K | 3.00K | 3.00K | 14.00K | -1.47M | |
| -1.18M | -1.54M | -2.46M | -3.03M | -17.33M | |
| -1.18M | -1.54M | -2.46M | -3.03M | -17.33M | |
| -1.18M | -1.54M | -2.46M | -3.03M | -17.33M | |
| -1.18M | -1.54M | -2.46M | -3.03M | -17.33M | |
| -0.08 | -0.11 | -0.18 | -0.23 | -1.30 | |
| -0.08 | -0.11 | -0.18 | -0.23 | -1.30 | |
| -0.08 | -0.11 | -0.18 | -0.23 | -1.30 | |
| -1.17M | -1.54M | -2.45M | -3.01M | -17.28M | |
| -1.17M | -1.54M | -2.45M | -3.01M | -17.28M | |
| 14.30M | 13.52M | 13.41M | 13.38M | 13.35M | |
| 14.30M | 13.52M | 13.41M | 13.38M | 13.35M |